comparemela.com
Latest Breaking News On - Steve ruchefsky - Page 1 : comparemela.com
Regel Therapeutics Awarded $1 Million from HS Chau Women in Enterprising Science Program at the Innovative Genomics Institute to Continue Developing Its Gene Modulation Technology
/PRNewswire/ Regel Therapeutics, a next generation gene therapy company utilizing proprietary technology to modulate gene expression, today announced that.
Berkeley
California
United-states
Cambridge
Cambridgeshire
United-kingdom
Solina-chau-hoi-shuen
Emmanuelle-charpentier
Jennifer-doudna
Steve-ruchefsky
Navneet-matharu
Innovative-genomics-institute
Regel Therapeutics details its proprietary T3 platform and development pipeline on its newly launched website, expands its Board of Directors and announces its Scientific Advisory Board.
/PRNewswire/ Regel Therapeutics, a next generation gene therapy company utilizing proprietary technology to develop clinical products modulating gene.
Berkeley
California
United-states
Cambridge
Cambridgeshire
United-kingdom
San-francisco
Wendy-chung
Orrin-devinsky
Steve-ruchefsky
Andrew-schiermeier
Nadav-ahituv
vimarsana © 2020. All Rights Reserved.